Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.879
-0.005 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
0.876
-0.003 (-0.36%)
After-hours: Apr 28, 2026, 7:55 PM EDT
RVPH Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 8.49 | 7.89 | 8.08 | 5.36 | 5.25 | |
| Research & Development | 11.71 | 22.91 | 31.42 | 22.87 | 4.85 | |
| Operating Expenses | 20.2 | 30.8 | 39.5 | 28.23 | 10.1 | |
| Operating Income | -20.2 | -30.8 | -39.5 | -28.23 | -10.1 | |
| Interest Expense | -0.01 | -0.02 | -0.03 | - | -0 | |
| Interest & Investment Income | 0.31 | 0.36 | 0.4 | 0.18 | - | |
| Other Non Operating Income (Expenses) | 0.06 | 0.56 | -0.1 | -0.19 | 1.59 | |
| Pretax Income | -19.85 | -29.9 | -39.24 | -28.24 | -8.52 | |
| Income Tax Expense | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Net Income | -19.86 | -29.92 | -39.26 | -28.26 | -8.52 | |
| Net Income to Common | -19.86 | -29.92 | -39.26 | -28.26 | -8.52 | |
| Shares Outstanding (Basic) | 4 | 2 | 1 | 1 | 1 | |
| Shares Outstanding (Diluted) | 4 | 2 | 1 | 1 | 1 | |
| Shares Change (YoY) | 114.96% | 41.84% | 21.94% | 31.95% | 383.10% | |
| EPS (Basic) | -5.48 | -17.73 | -32.99 | -28.96 | -11.52 | |
| EPS (Diluted) | -5.48 | -17.73 | -32.99 | -28.96 | -11.52 | |
| EBITDA | - | - | - | - | -10.1 | |
| D&A For EBITDA | - | - | - | - | 0 | |
| EBIT | -20.2 | -30.8 | -39.5 | -28.23 | -10.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.